Zhejiang Shouxiangu Pharmaceutical Holding Co. Ltd. Class ASSE: 603896

Announcement on Convening the Q3 2025 Performance Briefing

· Issued by Zhejiang Shouxiangu Pharmaceutical Holding Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Convening the Q3 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment